Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 8
2007 5
2008 5
2009 5
2010 7
2011 4
2012 1
2013 3
2014 4
2015 8
2016 9
2017 9
2018 10
2019 9
2020 9
2021 10
2022 11
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial.
Simon D, Minopoulou I, Kemenes S, Bayat S, Tascilar K, Mutlu MY, Valor-Méndez L, Krönke G, Hueber AJ, Schett G, Kleyer A. Simon D, et al. Among authors: hueber aj. Arthritis Rheumatol. 2023 Nov;75(11):1923-1934. doi: 10.1002/art.42617. Epub 2023 Sep 21. Arthritis Rheumatol. 2023. PMID: 37229650 Clinical Trial.
Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.
Kampylafka E, Simon D, d'Oliveira I, Linz C, Lerchen V, Englbrecht M, Rech J, Kleyer A, Sticherling M, Schett G, Hueber AJ. Kampylafka E, et al. Among authors: hueber aj. Arthritis Res Ther. 2019 Jul 26;21(1):178. doi: 10.1186/s13075-019-1957-0. Arthritis Res Ther. 2019. PMID: 31349876 Free PMC article. Clinical Trial.
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber AJ, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler DM, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester GR, Karberg K, Strunk J, Cañete JD, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino MA, Østergaard M, Schett G. Rech J, et al. Among authors: hueber aj. Lancet. 2024 Mar 2;403(10429):850-859. doi: 10.1016/S0140-6736(23)02650-8. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364841 Clinical Trial.
Nanoparticles and inflammation.
Stevenson R, Hueber AJ, Hutton A, McInnes IB, Graham D. Stevenson R, et al. Among authors: hueber aj. ScientificWorldJournal. 2011 Jun 9;11:1300-12. doi: 10.1100/tsw.2011.106. ScientificWorldJournal. 2011. PMID: 21666995 Free PMC article. Review.
[Big data in imaging].
Sewerin P, Ostendorf B, Hueber AJ, Kleyer A. Sewerin P, et al. Among authors: hueber aj. Z Rheumatol. 2018 Apr;77(3):203-208. doi: 10.1007/s00393-018-0422-9. Z Rheumatol. 2018. PMID: 29411097 Review. German.
An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis.
Watson L, Coyle C, Whately-Smith C, Brooke M, Kiltz U, Lubrano E, Queiro R, Trigos D, Brandt-Juergens J, Choy E, D'Angelo S, Delle Sedie A, Dernis E, Guis S, Helliwell P, Ho P, Hueber AJ, Joven B, Koehm M, Montilla C, Packham J, Pinto Tasende JA, Ramirez Garcia FJ, Ruyssen-Witrand A, Scrivo R, Twigg S, Soubrier M, Wirth T, Gossec L, Coates LC. Watson L, et al. Among authors: hueber aj. Rheumatology (Oxford). 2023 Nov 27:kead621. doi: 10.1093/rheumatology/kead621. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38011669
114 results